{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:30:45Z","timestamp":1785443445320,"version":"3.56.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.atherosclerosis.2023.01.017","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T03:48:45Z","timestamp":1674186525000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Impact of lipid lowering on coronary atherosclerosis moving from the lumen to the artery wall"],"prefix":"10.1016","volume":"367","author":[{"given":"Giuseppe","family":"Di Giovanni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Bubb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib1","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib2","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib3","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib4","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib5","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib6","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1161\/01.CIR.90.6.2645","article-title":"Long-term survival of medically treated patients in the coronary artery surgery study (CASS) registry","volume":"90","author":"Emond","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0002-9149(81)90156-9","article-title":"Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the Collaborative Study in Coronary Artery Surgery (CASS)","volume":"48","author":"Chaitman","year":"1981","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.CIR.92.3.657","article-title":"Coronary plaque disruption","volume":"92","author":"Falk","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib9","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.jacc.2010.02.026","article-title":"Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome","volume":"55","author":"Nicholls","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41569-022-00687-9","article-title":"Optical coherence tomography in coronary atherosclerosis assessment and intervention","volume":"19","author":"Araki","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib12","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0140-6736(19)31794-5","article-title":"Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study","volume":"394","author":"Waksman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib13","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.jacc.2016.08.055","article-title":"A prospective natural history study of coronary atherosclerosis using fractional flow reserve","volume":"68","author":"Barbato","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/CIRCRESAHA.116.307971","article-title":"Noninvasive molecular imaging of disease activity in atherosclerosis","volume":"119","author":"Dweck","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib15","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/CIRCULATIONAHA.122.060308","article-title":"Noninvasive plaque imaging to accelerate coronary artery disease drug development","volume":"146","author":"Figtree","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/ATVBAHA.118.311756","article-title":"Emerging magnetic resonance imaging techniques for atherosclerosis imaging","volume":"39","author":"Wust","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib17","doi-asserted-by":"crossref","first-page":"5M","DOI":"10.1016\/S0002-9149(98)00591-8","article-title":"Clinical trial endpoints: angiograms, events, and plaque instability","volume":"82","author":"Ballantyne","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib18","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIRCULATIONAHA.108.773747","article-title":"Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden","volume":"117","author":"Ballantyne","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib19","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.CIR.93.10.1826","article-title":"LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis","volume":"93","author":"Kroon","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib20","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIRCULATIONAHA.108.773747","article-title":"Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography. A study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden","volume":"117","author":"Ballantyne","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib21","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.291.9.1071","article-title":"Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial","volume":"291","author":"Nissen","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa042000","article-title":"Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease","volume":"352","author":"Nissen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib23","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","article-title":"Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial","volume":"295","author":"Nissen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jama.297.5.499","article-title":"Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis","volume":"297","author":"Nicholls","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib25","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1110874","article-title":"Effect of two intensive statin regimens on progression of coronary disease","volume":"365","author":"Nicholls","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jacc.2009.04.033","volume":"54","author":"Hiro","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib27","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/01.CIR.0000140261.58966.A4","article-title":"Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study","volume":"110","author":"Okazaki","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib28","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1161\/ATVBAHA.114.303932","article-title":"Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: effect of Rosuvastatin versus Atorvastatin","volume":"34","author":"Puri","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib29","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.jacc.2010.01.050","article-title":"Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol","volume":"55","author":"Bayturan","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jacc.2015.05.065","article-title":"Impact of dual lipid-lowering strategy with ezetimibe and atorvastatin on coronary plaque regression in patients with percutaneous coronary intervention: the multicenter randomized controlled PRECISE-IVUS trial","volume":"66","author":"Tsujita","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib31","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2016.16951","article-title":"Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial","volume":"316","author":"Nicholls","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib32","article-title":"Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI randomized clinical trial","author":"Raber","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmg.2022.03.002","article-title":"Effect of evolocumab on coronary plaque phenotype and burden in statin-treated patients following myocardial infarction","author":"Nicholls","year":"2022","journal-title":"JACC Cardiovasc Imag."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib34","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/ehjci\/jeu065","article-title":"Progression of coronary atherosclerosis in stable patients with ultrasonic features of high-risk plaques","volume":"15","author":"Kataoka","year":"2014","journal-title":"Europ. Heart J. Cardiovasc. Imag."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib35","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jacc.2015.01.036","article-title":"Impact of statins on serial coronary calcification during atheroma progression and regression","volume":"65","author":"Puri","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/ehjci\/jet251","article-title":"Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN","volume":"15","author":"Puri","year":"2014","journal-title":"Europ. Heart J. Cardiovasc. Imag."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib37","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/j.jacc.2018.06.078","article-title":"Effect of evolocumab on coronary plaque composition","volume":"72","author":"Nicholls","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12916-015-0459-4","article-title":"Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies","volume":"13","author":"Banach","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib39","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/jamacardio.2019.5315","article-title":"Association of high-density calcified 1K plaque with risk of acute coronary syndrome","volume":"5","author":"van Rosendael","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib40","doi-asserted-by":"crossref","first-page":"734","DOI":"10.4244\/EIJV12I6A118","article-title":"Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries","volume":"12","author":"Oemrawsingh","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib41","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/eurheartj\/ehu373","article-title":"Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study","volume":"36","author":"Raber","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib42","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ahj.2007.11.018","article-title":"Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial","volume":"155","author":"Underhill","year":"2008","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib43","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.atherosclerosis.2015.08.005","article-title":"Plaque microstructures in patients with coronary artery disease who achieved very low low-density lipoprotein cholesterol levels","volume":"242","author":"Kataoka","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib44","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.amjcard.2014.05.035","article-title":"Frequency-domain optical coherence tomographic analysis of plaque microstructures at nonculprit narrowings in patients receiving potent statin therapy","volume":"114","author":"Kataoka","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/MCA.0000000000000465","article-title":"Is age an important factor for vascular response to statin therapy? A serial optical coherence tomography and intravascular ultrasound study","volume":"28","author":"Dai","year":"2017","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jcmg.2011.11.012","article-title":"Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS","volume":"5","author":"Hattori","year":"2012","journal-title":"JACC Cardiovasc Imag."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib47","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.amjcard.2015.11.062","article-title":"Comparison of intensive versus moderate lipid-lowering therapy on fibrous cap and atheroma volume of coronary lipid-rich plaque using serial optical coherence tomography and intravascular ultrasound imaging","volume":"117","author":"Hou","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib48","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.jacc.2014.08.045","article-title":"Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study","volume":"64","author":"Komukai","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib49","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.atherosclerosis.2014.02.025","article-title":"Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheroma","volume":"234","author":"Nishio","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib50","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.atherosclerosis.2008.05.014","article-title":"Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study","volume":"202","author":"Takarada","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib51","doi-asserted-by":"crossref","first-page":"120","DOI":"10.21037\/cdt-20-684","article-title":"Assessing the impact of PCSK9 inhibition on coronary plaque phenotype with optical coherence tomography: rationale and design of the randomized, placebo-controlled HUYGENS study","volume":"11","author":"Nicholls","year":"2021","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib52","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.amjcard.2013.10.038","article-title":"Impact on optical coherence tomographic coronary findings of fluvastatin alone versus fluvastatin + ezetimibe","volume":"113","author":"Habara","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jjcc.2019.08.002","article-title":"Effect of evolocumab therapy on coronary fibrous cap thickness assessed by optical coherence tomography in patients with acute coronary syndrome","volume":"75","author":"Yano","year":"2020","journal-title":"J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jacc.2013.03.058","article-title":"Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy)","volume":"62","author":"Kini","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib56","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.atherosclerosis.2019.03.005","article-title":"Coronary atheroma regression and adverse cardiac events: a systematic review and meta-regression analysis","volume":"284","author":"Bhindi","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib57","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5551\/jat.6551","article-title":"Plaque regression determined by intravascular ultrasound predicts long-term outcomes of patients with acute coronary syndrome","volume":"18","author":"Dohi","year":"2011","journal-title":"J. Atherosclerosis Thromb."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib58","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.jacc.2017.03.556","article-title":"Clinical significance of lipid-rich plaque detected by optical coherence tomography: a 4-year follow-up study","volume":"69","author":"Xing","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.01.017_bib59","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/eurheartj\/ehz520","article-title":"Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study","volume":"41","author":"Prati","year":"2020","journal-title":"Eur. Heart J."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023000291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023000291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:50:43Z","timestamp":1758156643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915023000291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":58,"alternative-id":["S0021915023000291"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.01.017","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of lipid lowering on coronary atherosclerosis moving from the lumen to the artery wall","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}